Searchable abstracts of presentations at key conferences in endocrinology

ea0034p8 | Bone | SFEBES2014

Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice

Pereira Marie , Jeyabalan Jeshmi , Jorgensen Camilla Sofie , Cleasby Mark , Hopkinson Mark , Chenu Chantal

The increased incidence of type 2 diabetes mellitus (T2DM) among the aged is associated with an impaired skeletal structure and a higher prevalence for bone fractures. Besides, anti-diabetic therapies can also negatively affect bone mass. In this study, we tested the skeletal effects of chronic administration of two glucagon-like peptide receptor (GLP-1R) agonists and examined the expression of GLP-1R in bone tissue and cells. Twelve week-old female C57Bl/6N mice were ovariect...

ea0013oc12 | Clinical and translational endocrinology | SFEBES2007

Local and systemic consequences of glucocorticoid metabolism in synovium

Hardy Rowan , Cooper Mark Stewart Paul , Buckley Chris , Raza Kirim , Rabbitt Elizabeth , Cooper Mark

Therapeutic glucocorticoids are used in rheumatoid arthritis (RA) to reduce inflammation and bone destruction. We recently reported that primary synovial fibroblasts generate active glucocorticoids via expression of 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This enzyme activates cortisol from inactive cortisone (and prednisolone from prednisone) and this activity is up-regulated by inflammation. We have now examined glucocorticoid metabolism in synovial tissu...

ea0099p323 | Pituitary and Neuroendocrinology | ECE2024

Predictors of corticotroph tumour recurrence after surgical resection

Fookeerah Prishila , Varikatt Winny , Shingde Meena , Dexter Mark , Lynn Lau Sue , McLean Mark

Background: Corticotroph tumours are a heterogenous group of pituitary neuroendocrine tumours (PitNETs) in terms of their histological type, clinical presentation and tumour behaviour. These tumours are overrepresented in recurrent PitNETs and pose an important clinical and therapeutic challenge1. Although risk factors such as radiological invasion and elevated proliferative markers have been identified for PitNET recurrence, an improvement in proposed prognostic mo...

ea0099p342 | Pituitary and Neuroendocrinology | ECE2024

Is histological subtyping important in the prognostication of acromegaly?

Fookeerah Prishila , Varikatt Winny , Dexter Mark , Lynn Lau Sue , McLean Mark

Background: Pituitary neuroendocrine tumours (PitNETs) that cause acromegaly are often collectively categorised as ‘growth hormone (GH) secreting adenomas’. The 2022 WHO classification however identifies 7 histological variants that can secrete GH: densely granulated somatotroph (DGST), sparsely granulated somatotroph (SGST), mammosomatotroph (MST), mixed somatotroph and lactotroph (MSLT), mature plurihormonal PIT1 (MPPT), immature PIT1 (IPT) and acidophil stem cell ...

ea0099ep381 | Pituitary and Neuroendocrinology | ECE2024

Secondary radiation-induced sarcoma occurring as a rare complication of radiotherapy for a gonadotroph tumour

Fookeerah Prishila , Bayly Angela , Varikatt Winny , Smee Robert , Dexter Mark , Lynn Lau Sue , McLean Mark

Background: Secondary malignant sarcoma in the sella after radiotherapy for pituitary tumours is rare. Osteogenic sarcoma arising within the fossa after pituitary irradiation has only been described in a few case reports.Clinical Case: A 31-year-old male patient without significant medical History presented in 2012 with bitemporal hemianopia. There were no associated headaches or clinical features of excess hormone secretion. MRI demonstrated a 26×3...

ea0077p60 | Metabolism, Obesity and Diabetes | SFEBES2021

Mimicking chronic hyperglycaemic conditions in primary human endothelial cell cultures using pathophysiological concentrations of glucose in prediabetes and type 2 diabetes

Luk Cheukyau , Haywood Natalie J , Kearney Mark T

Introduction: In the UK alone, diabetes affects nearly 4 million people and an additional 13.6 million people are estimated to be at high risk of developing type 2 diabetes (T2DM). Diabetes is associated with vascular complications which path the development of cardiovascular diseases such as strokes and heart attacks. Previous studies have shown various pathways in which hyperglycaemia leads to endothelial dysfunction and insulin resistance. However, current reports of <e...

ea0077p222 | Neuroendocrinology and Pituitary | SFEBES2021

SDHD missense pathogenic variants: not always benign

Haboosh Sara , Carroll Paul , Izatt Louise , Quinn Mark , Velusamy Anand

Pathogenic variants in the SDHx genes are responsible for ~20% of familial Phaeochromocytoma/Paraganglioma (PPGL) tumours. Metastatic disease is lower in SDHD in comparison to SDHA, B and C mutations. Although the genotype-phenotype relationship is not well established it is considered that truncating SDHD pathogenic variants have a higher risk of causing disease in comparison to missense variants. We present two cases of metastatic paraganglioma in patients with heterozygous ...

ea0055p15 | Poster Presentations | SFEEU2018

A surgical treatment for cardiomyopathy

Kirresh Omar , Gurnell Mark , Drake William , Chung Teng Teng

Case history: A 59 year old Afro-Carribbean male with a 25 year history of cardiac enlargement and hypertension, on multiple anti-hypertensives, presented with increasing breathlessness and several years of markedly reduced exercise tolerance. He was intolerant of spironolactone and eplerenone. His past medical history included hypertersion, obstructive sleep apnoea, Steven-Johnson syndrome secondary to allopurinol, thyrotoxicosis treated with radio-active iodine, monoclonal g...

ea0078oc4.5 | Oral Communications 4 | BSPED2021

The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population

Watts Gemma , Young Aneurin , Johnson Mark John , Chowdhury Olie

Background: MBDP describes inadequate mineralisation of bones in the preterm infant. Traditionally, neonatologists have used a raised ALP and low phosphate to diagnose MBDP, with phosphate supplements as first-line treatment. An alternative management approach, published by Chinoy et al (2019), recommended PTH and vitamin D in the routine work-up. Objectives: We undertook a review of data across two neonatal intensive care units:<p class="ab...

ea0081p541 | Adrenal and Cardiovascular Endocrinology | ECE2022

Gender and age-matched case control study of a cohort of adrenal adenomas

Imbroll Miriam Giordano , Agius Stefanie , Craus Sarah , Gruppetta Mark

Background: The majority of adrenal incidentalomas are benign and patients can be reassured, but a personalized and multidisciplinary approach is required when dealing with these lesions, since they might be linked with various comorbidities. The aim of our study was to carry out an in-depth analysis of the biochemical workup of adrenal incidentalomas and comparing the results with controls. Methods: 252 patients with an incidentally discovered adrenal a...